Table 3.
Gene stability ranking: The ten most stable genes selected on the basis of lowest CoVs, or by inputting Ct values into GeNorm and Normfinder algorithms from the prospective bladder cancer cohort and TCGA bladder cancer cohort. (*’common’ refers to genes which appear in the top ten most stable genes in all three measures of stability (CoV, GeNorm and Normfinder)).
| Rank | CoV | GeNorm | NormFinder | Common* | ||||
|---|---|---|---|---|---|---|---|---|
| Prospective bladder cancer cohort | ||||||||
| 1 | SDHA | SDHA | HMBS | UBC | ||||
| 2 | IPO8 | IPO8 | PGK1 | RPLP0 | ||||
| 3 | POLR2A | UBC | UBC | HMBS | ||||
| 4 | HMBS | GUSB | GAPDH | GUSB | ||||
| 5 | GUSB | RPLP0 | PPIA | TBP | ||||
| 6 | TBP | HMBS | GUSB | |||||
| 7 | UBC | PPIA | TBP | |||||
| 8 | RPLP0 | RPL11 | GNB2L1 | |||||
| 9 | HPRT1 | GAPDH | RPLP0 | |||||
| 10 | YMHAZ | TBP | HPRT1 | |||||
| TCGA bladder cancer cohort | ||||||||
| 1 | TBP | RPL11 | PPIA | TBP | ||||
| 2 | PPIA | RPL24 | TBP | PPIA | ||||
| 3 | IPO8 | GNB2L1 | UBC | HMBS | ||||
| 4 | UBC | RPLP0 | IPO8 | RPL11 | ||||
| 5 | POLR2A | PPIA | RPL11 | |||||
| 6 | RPL11 | TBP | HMBS | |||||
| 7 | ACTB | HPRT1 | SDHA | |||||
| 8 | YWHAZ | HMBS | GAPDH | |||||
| 9 | HMBS | GUSB | RPLP0 | |||||
| 10 | RPL24 | POLR2A | HPRT1 | |||||